Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2194)	2/4/2008 9:39:29 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

CTIC Is finding resistance at the $1.72 level & may close its Jan 31 UG, in spite of its plans to cut its NOE by 35% <g> bigcharts.marketwatch.com It said that it plans to expand & support its Zevalin sales & plans to file MAA in the 1stQ for its XYOTAX & also plans an NDA for its Pixantrone after releasing results of the PIII. Will also continue the PII of Brostallicin.It plans to file for approval of XYOTAX in Europe in March. CTIC has trimmed its losses in the last 4Qs but the EL for 2007 is still around $2.70 & for 2008 is still around $2.30 But if CTIC can cut more its losses & close above $2.50 it may be able to reverse its DT.(Don't expect for it to be able to close some of its March 2005 DG above the $14 level this Yr.<g>) bigcharts.marketwatch.com Bernard